NRF2 REGULATORS
The invention relates to aryl analogs of formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds and their use as NRF2 regulators. Изобретение относится к арильным аналогам формулы (I) и их фармацевтически приемлемым солям, фармацевтическим ко...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; rus |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KERNS, Jeffrey K LAKDAWALA SHAH, Ami LI, Tindy CALLAHAN, James Francis DAVIS, Roderic S GRIFFITHS-JONES, Charlotte Mary YAN, Hongxing BOEHM, Jeffrey Charles WOOLFORD, Alison Jo-Anne HAMILTON, Paris L HEIGHTMAN, Thomas Daniel NORTON, David JIN, Yun GOODWIN, Nicole Cathleen |
| description | The invention relates to aryl analogs of formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds and their use as NRF2 regulators.
Изобретение относится к арильным аналогам формулы (I) и их фармацевтически приемлемым солям, фармацевтическим композициям, содержащим такие соединения, и их применению в качестве регуляторов NRF2. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EA035864B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EA035864B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EA035864B13</originalsourceid><addsrcrecordid>eNrjZOD3C3IzUghydQ_1cQzxDwrmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxro4GxqYWZiZOhsaEVQAAdH4cVA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NRF2 REGULATORS</title><source>esp@cenet</source><creator>KERNS, Jeffrey K ; LAKDAWALA SHAH, Ami ; LI, Tindy ; CALLAHAN, James Francis ; DAVIS, Roderic S ; GRIFFITHS-JONES, Charlotte Mary ; YAN, Hongxing ; BOEHM, Jeffrey Charles ; WOOLFORD, Alison Jo-Anne ; HAMILTON, Paris L ; HEIGHTMAN, Thomas Daniel ; NORTON, David ; JIN, Yun ; GOODWIN, Nicole Cathleen</creator><creatorcontrib>KERNS, Jeffrey K ; LAKDAWALA SHAH, Ami ; LI, Tindy ; CALLAHAN, James Francis ; DAVIS, Roderic S ; GRIFFITHS-JONES, Charlotte Mary ; YAN, Hongxing ; BOEHM, Jeffrey Charles ; WOOLFORD, Alison Jo-Anne ; HAMILTON, Paris L ; HEIGHTMAN, Thomas Daniel ; NORTON, David ; JIN, Yun ; GOODWIN, Nicole Cathleen</creatorcontrib><description>The invention relates to aryl analogs of formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds and their use as NRF2 regulators.
Изобретение относится к арильным аналогам формулы (I) и их фармацевтически приемлемым солям, фармацевтическим композициям, содержащим такие соединения, и их применению в качестве регуляторов NRF2.</description><language>eng ; rus</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200821&DB=EPODOC&CC=EA&NR=035864B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200821&DB=EPODOC&CC=EA&NR=035864B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KERNS, Jeffrey K</creatorcontrib><creatorcontrib>LAKDAWALA SHAH, Ami</creatorcontrib><creatorcontrib>LI, Tindy</creatorcontrib><creatorcontrib>CALLAHAN, James Francis</creatorcontrib><creatorcontrib>DAVIS, Roderic S</creatorcontrib><creatorcontrib>GRIFFITHS-JONES, Charlotte Mary</creatorcontrib><creatorcontrib>YAN, Hongxing</creatorcontrib><creatorcontrib>BOEHM, Jeffrey Charles</creatorcontrib><creatorcontrib>WOOLFORD, Alison Jo-Anne</creatorcontrib><creatorcontrib>HAMILTON, Paris L</creatorcontrib><creatorcontrib>HEIGHTMAN, Thomas Daniel</creatorcontrib><creatorcontrib>NORTON, David</creatorcontrib><creatorcontrib>JIN, Yun</creatorcontrib><creatorcontrib>GOODWIN, Nicole Cathleen</creatorcontrib><title>NRF2 REGULATORS</title><description>The invention relates to aryl analogs of formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds and their use as NRF2 regulators.
Изобретение относится к арильным аналогам формулы (I) и их фармацевтически приемлемым солям, фармацевтическим композициям, содержащим такие соединения, и их применению в качестве регуляторов NRF2.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOD3C3IzUghydQ_1cQzxDwrmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxro4GxqYWZiZOhsaEVQAAdH4cVA</recordid><startdate>20200821</startdate><enddate>20200821</enddate><creator>KERNS, Jeffrey K</creator><creator>LAKDAWALA SHAH, Ami</creator><creator>LI, Tindy</creator><creator>CALLAHAN, James Francis</creator><creator>DAVIS, Roderic S</creator><creator>GRIFFITHS-JONES, Charlotte Mary</creator><creator>YAN, Hongxing</creator><creator>BOEHM, Jeffrey Charles</creator><creator>WOOLFORD, Alison Jo-Anne</creator><creator>HAMILTON, Paris L</creator><creator>HEIGHTMAN, Thomas Daniel</creator><creator>NORTON, David</creator><creator>JIN, Yun</creator><creator>GOODWIN, Nicole Cathleen</creator><scope>EVB</scope></search><sort><creationdate>20200821</creationdate><title>NRF2 REGULATORS</title><author>KERNS, Jeffrey K ; LAKDAWALA SHAH, Ami ; LI, Tindy ; CALLAHAN, James Francis ; DAVIS, Roderic S ; GRIFFITHS-JONES, Charlotte Mary ; YAN, Hongxing ; BOEHM, Jeffrey Charles ; WOOLFORD, Alison Jo-Anne ; HAMILTON, Paris L ; HEIGHTMAN, Thomas Daniel ; NORTON, David ; JIN, Yun ; GOODWIN, Nicole Cathleen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EA035864B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2020</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>KERNS, Jeffrey K</creatorcontrib><creatorcontrib>LAKDAWALA SHAH, Ami</creatorcontrib><creatorcontrib>LI, Tindy</creatorcontrib><creatorcontrib>CALLAHAN, James Francis</creatorcontrib><creatorcontrib>DAVIS, Roderic S</creatorcontrib><creatorcontrib>GRIFFITHS-JONES, Charlotte Mary</creatorcontrib><creatorcontrib>YAN, Hongxing</creatorcontrib><creatorcontrib>BOEHM, Jeffrey Charles</creatorcontrib><creatorcontrib>WOOLFORD, Alison Jo-Anne</creatorcontrib><creatorcontrib>HAMILTON, Paris L</creatorcontrib><creatorcontrib>HEIGHTMAN, Thomas Daniel</creatorcontrib><creatorcontrib>NORTON, David</creatorcontrib><creatorcontrib>JIN, Yun</creatorcontrib><creatorcontrib>GOODWIN, Nicole Cathleen</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KERNS, Jeffrey K</au><au>LAKDAWALA SHAH, Ami</au><au>LI, Tindy</au><au>CALLAHAN, James Francis</au><au>DAVIS, Roderic S</au><au>GRIFFITHS-JONES, Charlotte Mary</au><au>YAN, Hongxing</au><au>BOEHM, Jeffrey Charles</au><au>WOOLFORD, Alison Jo-Anne</au><au>HAMILTON, Paris L</au><au>HEIGHTMAN, Thomas Daniel</au><au>NORTON, David</au><au>JIN, Yun</au><au>GOODWIN, Nicole Cathleen</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NRF2 REGULATORS</title><date>2020-08-21</date><risdate>2020</risdate><abstract>The invention relates to aryl analogs of formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds and their use as NRF2 regulators.
Изобретение относится к арильным аналогам формулы (I) и их фармацевтически приемлемым солям, фармацевтическим композициям, содержащим такие соединения, и их применению в качестве регуляторов NRF2.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; rus |
| recordid | cdi_epo_espacenet_EA035864B1 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | NRF2 REGULATORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T23%3A25%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KERNS,%20Jeffrey%20K&rft.date=2020-08-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEA035864B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |